Barcellona D |
Doris BarcellonaRicercatoreSSD: MED/09 SCIENZE MEDICHE INTERNISTICHE 'M.ARESU'
ELENCO DELLE 10 PUBBLICAZIONI CARATTERIZZANTI1. Pengo V, Biasiolo A, Gresele P, Marongiu F, Erba N, Veschi F, Ghirarduzzi A, De Candia E, Montaruli B, Testa S, Barcellona D, Tripodi A; Participating Centres of Italian Federation of Thrombosis Centres (FCSA). Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost. 2007; 5:925-30. 2. Barcellona D, Contu P, Marongiu F. A “two step” educational approach with anticoagulated patients does not improve therapy control. Journal of Thrombosis and Thrombolysis 2006; 22:185-90. 3. Barcellona D, fenu L, Minozzi M. Oral anticoagulant therapy and telemedicine. Intern Emerg Med 2006; 1:166-167. 4. Marongiu F, Barcellona D. The future of anticoagulation clinics: a journey to thrombosis centers? Haematologica 2005; 90:298-301. 5. Cauli C, Barcellona D, Marongiu F. Oral anticoagulant therapy in the primary and secondary prophylaxis of stroke. Ital Heart J 2003; 4:755-67. 6. Barcellona D, Fenu L, Cauli C, Pisu G, Marongiu F. Allele 4G of gene PAI-I associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thromb Haemost 2003; 90:161-4. 7. Barcellona D, Fenu L, Marongiu F. Oral anticoagulant therapy: should doctors change the way they give patients explanations ? Thromb Haemost 2003; 90:159-60. 8. Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica: 2002; 87:1081-86. 9. Barcellona D, Contu P, Sorano GG, Pengo V, Marongiu F. The management of oral anticoagulant therapy: the patient’s point of view. Thromb Haemost 2000; 83:49-53. 10.Barcellona D, Vannini ML, Fenu L, Belestrieri C, Marongiu F. Warfarin or Acenocoumarol: which is better in the management of oral anticoagulants? Thrombosis and Haemostasis 1998; 80:899-902.
|